Saebeom Hur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saebeom Hur has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Hwan Jun Jae
Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
10 shared publications - Jin Wook Chung
Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
8 shared publications - Hyo-Cheol Kim
Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
6 shared publications - Maxim Itkin
Penn Center for Lymphatic Disorders, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
6 shared publications - Myungsu Lee
Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea
5 shared publications - Seunghyun Lee
Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea
5 shared publications
Latest Publications
- 1 July 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 320 (1) , e252027
Intravenous MR Lymphangiography: Feasibility in a Swine Model and Proof-of-Concept in Patients
Intravenous MR lymphangiography allowed for the noninvasive visualization of the lymphatic system, including the hepatic and mesenteric lymphatics.
- 1 July 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 320 (1) , e252027
Intravenous MR Lymphangiography: Feasibility in a Swine Model and Proof-of-Concept in Patients
Intravenous MR lymphangiography allowed for the noninvasive visualization of the lymphatic system, including the hepatic and mesenteric lymphatics.
- Open Access
- 25 March 2026
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 17 (6) , 1024-1033
Diabetic foot ulcer‐related amputation is associated with twofold increased risk of cardiovascular disease: A Korean National Health Information Database Study
Aims: To quantify the risk of cardiovascular disease (CVD) and all‐cause mortality associated with diabetic foot ulcer (DFU)‐related amputation using a large‐scale, nationally representative cohort. Materials and Methods: This longitudinal study included individuals with diabetes who underwent standardized national health checkups between 2009 and 2012, with follow‐up data obtained from the Korean National Health Insurance Service claims database. CVD was defined as an incident myocardial infarction or stroke occurring after the index health checkup. Cox proportional hazards models were used to estimate the hazard ratios (HRs) for CVD and mortality in individuals with DFU‐related amputation compared with those with diabetes but without amputation. Results: Among 1,229,689 individuals with diabetes, 1,486 (0.12%) had a DFU‐related amputation at baseline. The median follow‐up was 8.2 years in the non‐amputation group and 6.7 years in the DFU‐related amputation group. People with DFU‐related amputation had a significantly higher incidence rate of CVD compared with those without DFU‐related amputation (32.6 vs. 11.0 per 1000 person‐years) with a HR of 1.9 (95% CI 1.6–2.1). The HRs for myocardial infarction and stroke were 2.2 (95% CI 1.9–2.6) and 1.6 (95% CI 1.4–1.8), respectively. All‐cause mortality significantly increased in people with DFU‐related amputation compared with those without, with an HR of 2.1 (95% CI 1.9–2.3). Conclusions: In this nationwide population‐based cohort, DFU‐related amputation was associated with nearly a twofold increased risk of cardiovascular events and mortality. These findings underscore the importance of comprehensive cardiovascular risk assessment and management in patients with diabetic foot complications.
- 25 March 2026
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 17 (6) , 1024-1033
Open AccessDiabetic foot ulcer‐related amputation is associated with twofold increased risk of cardiovascular disease: A Korean National Health Information Database Study
Aims: To quantify the risk of cardiovascular disease (CVD) and all‐cause mortality associated with diabetic foot ulcer (DFU)‐related amputation using a large‐scale, nationally representative cohort. Materials and Methods: This longitudinal study included individuals with diabetes who underwent standardized national health checkups between 2009 and 2012, with follow‐up data obtained from the Korean National Health Insurance Service claims database. CVD was defined as an incident myocardial infarction or stroke occurring after the index health checkup. Cox proportional hazards models were used to estimate the hazard ratios (HRs) for CVD and mortality in individuals with DFU‐related amputation compared with those with diabetes but without amputation. Results: Among 1,229,689 individuals with diabetes, 1,486 (0.12%) had a DFU‐related amputation at baseline. The median follow‐up was 8.2 years in the non‐amputation group and 6.7 years in the DFU‐related amputation group. People with DFU‐related amputation had a significantly higher incidence rate of CVD compared with those without DFU‐related amputation (32.6 vs. 11.0 per 1000 person‐years) with a HR of 1.9 (95% CI 1.6–2.1). The HRs for myocardial infarction and stroke were 2.2 (95% CI 1.9–2.6) and 1.6 (95% CI 1.4–1.8), respectively. All‐cause mortality significantly increased in people with DFU‐related amputation compared with those without, with an HR of 2.1 (95% CI 1.9–2.3). Conclusions: In this nationwide population‐based cohort, DFU‐related amputation was associated with nearly a twofold increased risk of cardiovascular events and mortality. These findings underscore the importance of comprehensive cardiovascular risk assessment and management in patients with diabetic foot complications.
- 11 August 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (11) , 1667-1677
Mesenteric Lymphangiography as a New Diagnostic and Therapeutic Tool for Refractory Chylous Lymphatic Leakages and Protein-Losing Enteropathy
- 11 August 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (11) , 1667-1677
Mesenteric Lymphangiography as a New Diagnostic and Therapeutic Tool for Refractory Chylous Lymphatic Leakages and Protein-Losing Enteropathy
- 14 July 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (8) , 1200-1204
Combined Percutaneous Sclerotherapy Plus Transarterial Embolization for Refractory Sports Injuries in Young Athletes: A Feasibility Study
Purpose To evaluate the feasibility and safety of combined percutaneous sclerotherapy plus transarterial embolization for refractory sports-related tendinopathy in young athletes. Materials and Methods Twelve athletes with 20 lesions (13 Achilles tendinopathies, 6 patellar tendinopathies, 1 iliotibial band syndrome), suffering pain persisting >3 months despite conservative management were included. Ultrasound-guided foam sclerosant was injected into the peri-tendinous subcutaneous tissue at the most painful area until approximately 50% pain relief was achieved. Immediately after the sclerotherapy, angiography was performed, and hypervascular neovessels at the pain site were embolized with a mixture of iondinated contrast medium and Imipenem/Cilastatin. Visual analog scale (VAS) scores were measured and peri- and post-procedural adverse events were recorded. Results Sclerosant injection produced an immediate ~50% pain reduction in all treated lesions, after which TAME was performed in 19 of 20 lesions (95%). Angiographic hypervascular staining was observed in 95% (19/20) of cases, facilitating targeted embolization. The mean sclerosant volume and imipenem amount were 1.4 ± 0.7 mL and 370.1 ± 14.9 mg, respectively. Mean VAS scores decreased from 6.7 ± 1.2 at baseline to 3.2 ± 1.1 at 1 week and 2.7 ± 0.8 at 6 months (p < 0.01). Clinical success was achieved in 18 of 20 lesions (90%), corresponding to 10 of 12 patients (83%). Minor complications occurred in 2 cases (2 groin hematomas), and all patients experienced mild post-injection soreness resolving within 4 days. No major complications or serious adverse events were observed. Conclusion The combined sclerotherapy plus embolization technique is feasible and safe for treating refractory lower-extremity tendinopathies in young athletes. Comparative studies are needed to assess potential added benefits. Graphical Abstract Imaging findings from a patient with Achilles tendinopathy treated with combined percutaneous sclerotherapy and transarterial embolization (sTAME). Upper panels: Ultrasonographic images obtained before (left) and immediately after (right) sclerosant injection, showing echogenic lines and acoustic shadowing (yellow arrows), indicative of sclerosant distribution within the lesion. Lower panels: Sagittal MRI demonstrates a lesion with high signal intensity at the Achilles tendon insertion (left, yellow arrow). Corresponding angiography performed immediately after sclerosant injection reveals prominent hypervascular staining at the lesion site (middle, yellow arrow), which resolved completely following embolization (right).
- 14 July 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (8) , 1200-1204
Combined Percutaneous Sclerotherapy Plus Transarterial Embolization for Refractory Sports Injuries in Young Athletes: A Feasibility Study
Purpose To evaluate the feasibility and safety of combined percutaneous sclerotherapy plus transarterial embolization for refractory sports-related tendinopathy in young athletes. Materials and Methods Twelve athletes with 20 lesions (13 Achilles tendinopathies, 6 patellar tendinopathies, 1 iliotibial band syndrome), suffering pain persisting >3 months despite conservative management were included. Ultrasound-guided foam sclerosant was injected into the peri-tendinous subcutaneous tissue at the most painful area until approximately 50% pain relief was achieved. Immediately after the sclerotherapy, angiography was performed, and hypervascular neovessels at the pain site were embolized with a mixture of iondinated contrast medium and Imipenem/Cilastatin. Visual analog scale (VAS) scores were measured and peri- and post-procedural adverse events were recorded. Results Sclerosant injection produced an immediate ~50% pain reduction in all treated lesions, after which TAME was performed in 19 of 20 lesions (95%). Angiographic hypervascular staining was observed in 95% (19/20) of cases, facilitating targeted embolization. The mean sclerosant volume and imipenem amount were 1.4 ± 0.7 mL and 370.1 ± 14.9 mg, respectively. Mean VAS scores decreased from 6.7 ± 1.2 at baseline to 3.2 ± 1.1 at 1 week and 2.7 ± 0.8 at 6 months (p < 0.01). Clinical success was achieved in 18 of 20 lesions (90%), corresponding to 10 of 12 patients (83%). Minor complications occurred in 2 cases (2 groin hematomas), and all patients experienced mild post-injection soreness resolving within 4 days. No major complications or serious adverse events were observed. Conclusion The combined sclerotherapy plus embolization technique is feasible and safe for treating refractory lower-extremity tendinopathies in young athletes. Comparative studies are needed to assess potential added benefits. Graphical Abstract Imaging findings from a patient with Achilles tendinopathy treated with combined percutaneous sclerotherapy and transarterial embolization (sTAME). Upper panels: Ultrasonographic images obtained before (left) and immediately after (right) sclerosant injection, showing echogenic lines and acoustic shadowing (yellow arrows), indicative of sclerosant distribution within the lesion. Lower panels: Sagittal MRI demonstrates a lesion with high signal intensity at the Achilles tendon insertion (left, yellow arrow). Corresponding angiography performed immediately after sclerosant injection reveals prominent hypervascular staining at the lesion site (middle, yellow arrow), which resolved completely following embolization (right).
- 13 March 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (7) , 1215-1217
Resolution of Postoperative Liver Lymphatic Leakage following Ethiodized Oil Injection without Embolization
- 13 March 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (7) , 1215-1217
Resolution of Postoperative Liver Lymphatic Leakage following Ethiodized Oil Injection without Embolization
- 21 January 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (5) , 833-843.e2
Lymphatic Embolization for Primary Genital Lymphorrhea and Chylous Reflux–Related Lower Limb Lymphedema
- 21 January 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (5) , 833-843.e2
Lymphatic Embolization for Primary Genital Lymphorrhea and Chylous Reflux–Related Lower Limb Lymphedema
- Open Access
- 1 January 2025
- Published by XMLink in Korean Journal of Radiology
- Vol. 26 (10) , 951-958
Percutaneous Lymphatic Embolization for Chylothorax Secondary to Gorham-Stout Disease
Lim DY, et al. Korean J Radiol. 2025 Oct;26(10):951-958. https://doi.org/10.3348/kjr.2025.0264
- 1 January 2025
- Published by XMLink in Korean Journal of Radiology
- Vol. 26 (10) , 951-958
Open AccessPercutaneous Lymphatic Embolization for Chylothorax Secondary to Gorham-Stout Disease
Lim DY, et al. Korean J Radiol. 2025 Oct;26(10):951-958. https://doi.org/10.3348/kjr.2025.0264
- 14 August 2024
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 60 (1) , 84-94
MR Lymphangiography
Congenital lymphatic flow disorders collectively refer to a heterogeneous group of diseases that manifest as chylothorax, chylous ascites, intestinal lymphangiectasia, protein-losing enteropathy, and peripheral extremity or genital lymphedema, all in the absence of identifiable injury to the lymphatic system. We have only recently begun to understand congenital lymphatic flow disorders through the ability to image lymph flow dynamically. Intranodal dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) is a crucial technique for imaging lymphatic flow in pediatric patients with congenital lymphatic flow disorders. However, as lymphatic imaging is still a nascent discipline with many uncertainties regarding optimal imaging and treatment, effective patient management requires a comprehensive understanding of imaging techniques, disease pathophysiology, and multidisciplinary treatment approaches. Above all, a fundamental understanding of the physiological lymphatic flow of the central conducting lymphatics is essential for the correct interpretation of DCMRL images. This knowledge helps to avoid unnecessary examinations, erroneous diagnoses, and potentially harmful treatment approaches. This review provides an overview of the methods, advantages, and precautions for interpreting the DCMRL examination, a state-of-the-art lymphatic system imaging technique, and shares various case studies.
- 14 August 2024
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 60 (1) , 84-94
MR Lymphangiography
Congenital lymphatic flow disorders collectively refer to a heterogeneous group of diseases that manifest as chylothorax, chylous ascites, intestinal lymphangiectasia, protein-losing enteropathy, and peripheral extremity or genital lymphedema, all in the absence of identifiable injury to the lymphatic system. We have only recently begun to understand congenital lymphatic flow disorders through the ability to image lymph flow dynamically. Intranodal dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) is a crucial technique for imaging lymphatic flow in pediatric patients with congenital lymphatic flow disorders. However, as lymphatic imaging is still a nascent discipline with many uncertainties regarding optimal imaging and treatment, effective patient management requires a comprehensive understanding of imaging techniques, disease pathophysiology, and multidisciplinary treatment approaches. Above all, a fundamental understanding of the physiological lymphatic flow of the central conducting lymphatics is essential for the correct interpretation of DCMRL images. This knowledge helps to avoid unnecessary examinations, erroneous diagnoses, and potentially harmful treatment approaches. This review provides an overview of the methods, advantages, and precautions for interpreting the DCMRL examination, a state-of-the-art lymphatic system imaging technique, and shares various case studies.
- Open Access
- 1 January 2024
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 85 (6) , 1044-1059
Study on the Necessity and Methodology for Enhancing Outpatient and Clinical Education in the Department of Radiology
조수범, et al. J Korean Soc Radiol. 2024 Nov;85(6):1044-1059. https://doi.org/10.3348/jksr.2023.0158
- 1 January 2024
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 85 (6) , 1044-1059
Open AccessStudy on the Necessity and Methodology for Enhancing Outpatient and Clinical Education in the Department of Radiology
조수범, et al. J Korean Soc Radiol. 2024 Nov;85(6):1044-1059. https://doi.org/10.3348/jksr.2023.0158